Dose Finding Study of Thymoglobulin (ATG) in Patients With Steroid-Refractory Acute Graft Versus Host Disease (aGVHD).
Phase of Trial: Phase I/II
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 20 Jan 2012 Actual patient number is 1 according to ClinicalTrials.gov.
- 20 Jan 2012 Planned end date Aug 2007 added as reported by ClinicalTrials.gov.
- 20 Jan 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.